West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
Brexit had bigger impact on UK economy than critics predicted, Rachel Reeves says - Brexit ‘needlessly’ added costs to UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback